Download App

Log in to access Online Inquiry
Company Overview More
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company’s products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
CEO: Sayer, Kevin Ronald
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

DXCM DexCom
321.230+5.110+1.62%
Post Mkt Price
322.490+1.26+0.39%
YOY
Do not show
Hide blank lines
(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31(Q3)2021/09/30
Assets
Current assets
Cash, cash equivalents and short term investments
2.11% 2.69B 0.87% 2.73B 0.87% 2.73B 3.61% 2.7B
-Cash and cash equivalents
-2.43% 716M 28.74% 1.05B 28.74% 1.05B 114.45% 1.44B
-Short-term investments
3.87% 1.97B -11.19% 1.68B -11.19% 1.68B -35.06% 1.25B
Receivables
22.8% 544.5M 20.02% 514.3M 20.02% 514.3M 43% 529.1M
-Accounts receivable
22.8% 544.5M 20.02% 514.3M 20.02% 514.3M 43% 529.1M
Inventory
18.12% 342.2M 52.24% 357.3M 52.24% 357.3M 75.04% 351.3M
Prepaid assets
116.25% 171.7M 51.39% 81.6M 51.39% 81.6M 24.44% 77.9M
Total current assets
8.75% 3.75B 7.58% 3.68B 7.58% 3.68B 12.95% 3.66B
Non current assets
Net PPE
36.31% 938.8M 46.22% 889.9M 46.22% 889.9M 49.88% 833.5M
-Gross PPE
39.85% 1.2B 47.01% 1.12B 16.66% 889.9M 49.61% 1.04B
-Accumulated depreciation
-54.01% -264.9M -50.13% -231.5M -- -- -48.5% -203M
Goodwill and other intangible assets
206.88% 58M 254.92% 68.5M 254.92% 68.5M 267.89% 69.9M
-Goodwill
40.74% 26.6M 37.31% 26.5M 37.31% 26.5M 25.79% 23.9M
-Other intangible assets
-- 31.4M -- 42M -- 42M -- 46M
Non current deferred assets
34.19% 290.8M 2.03% 220.8M 2.03% 220.8M -- 216.3M
Other non current assets
11.76% 22.8M -- -- -- -- -- --
Total non current assets
38.71% 1.31B 36.21% 1.18B 36.21% 1.18B 87.84% 1.12B
Total assets
15.2% 5.06B 13.36% 4.86B 13.36% 4.86B 24.59% 4.78B
Liabilities
Current liabilities
Payables
6.37% 183.8M 32.53% 236.7M 220.83% 573M 45.41% 244M
-accounts payable
-1.38% 150.1M 20.02% 196M 250.89% 573M 42.28% 210M
-Total tax payable
63.59% 33.7M 166.01% 40.7M -- -- 68.32% 34M
Current accrued expenses
14.91% 472.5M -0.89% 413.1M -69.96% 125.2M 37.69% 442.4M
Current debt and capital lease obligation
14.84% 20.9M 24.24% 20.5M 24.24% 20.5M 22.15% 19.3M
-Current capital lease obligation
14.84% 20.9M 24.24% 20.5M 24.24% 20.5M 22.15% 19.3M
Current deferred liabilities
42.11% 2.7M -4.55% 2.1M -4.55% 2.1M 53.33% 2.3M
Other current liabilities
-- -- -- 15M -- -- -- --
Current liabilities
17.76% 711.4M 17.38% 720.8M 17.38% 720.8M 45.12% 734.9M
Non current liabilities
Long term debt and capital lease obligation
14.37% 2.12B 1.94% 1.86B -1.19% 1.8B 3.41% 1.86B
-Long term debt
16.41% 1.97B 2.13% 1.7B 2.13% 1.7B 3.51% 1.7B
-Long term capital lease obligation
-6.4% 154.9M -0.13% 155.6M -36.71% 98.6M 2.42% 160.7M
Non current deferred liabilities
-- 6.1M -- 5.9M -- -- -- --
Other non current liabilities
4.26% 29.4M 0.74% 27.1M 234.57% 90M 64.11% 40.7M
Total non current liabilities
14.54% 2.16B 2.24% 1.89B 2.24% 1.89B 4.24% 1.9B
Total liabilities
15.33% 2.87B 6.01% 2.61B 6.01% 2.61B 13.11% 2.64B
Shareholders'equity
Share capital
0% 100K 0% 100K 0% 100K 0% 100K
-common stock
0% 100K 0% 100K 0% 100K 0% 100K
-Preferred stock
-- 0 -- 0 -- 0 -- 0
Retained earnings
245.86% 236M 76.55% -47.4M 76.55% -47.4M 94.98% -28M
Paid-in capital
-7.65% 2B 17.84% 2.5B 17.84% 2.5B 7.82% 2.32B
Less: Treasury stock
-62.7% 37.3M 106.2% 206.2M 106.2% 206.2M 59.5% 159.5M
Gains losses not affecting retained earnings
-310.34% -6.1M -84.38% 500K -84.38% 500K -50% 1.4M
Total stockholders'equity
15.03% 2.19B 23.27% 2.25B 23.27% 2.25B 42.47% 2.14B
Total equity
15.03% 2.19B 23.27% 2.25B 23.27% 2.25B 42.47% 2.14B
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
--Unqualified Opinion----

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%